scholarly article | Q13442814 |
P6179 | Dimensions Publication ID | 1005552924 |
P356 | DOI | 10.1007/BF03261837 |
P698 | PubMed publication ID | 22946769 |
P2093 | author name string | Stephen Kopecky | |
P2860 | cites work | Refining clinical risk stratification for predicting stroke and thromboembolism in atrial fibrillation using a novel risk factor-based approach: the euro heart survey on atrial fibrillation | Q35003773 |
Antithrombotic therapy for atrial fibrillation: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines | Q35752573 | ||
Guidelines for the management of atrial fibrillation: the Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology (ESC). | Q42923039 | ||
Acute stroke with atrial fibrillation. The Copenhagen Stroke Study. | Q51004375 | ||
ACC/AHA/ESC 2006 guidelines for the management of patients with atrial fibrillation--executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiolog | Q51935524 | ||
Oral anticoagulants vs aspirin in nonvalvular atrial fibrillation: an individual patient meta-analysis | Q28194233 | ||
Reversal of rivaroxaban and dabigatran by prothrombin complex concentrate: a randomized, placebo-controlled, crossover study in healthy subjects | Q28247385 | ||
Dabigatran versus warfarin in patients with atrial fibrillation | Q28256895 | ||
Adherence to Medication | Q28314923 | ||
Validation of Clinical Classification Schemes for Predicting Stroke | Q29028208 | ||
Prevalence of diagnosed atrial fibrillation in adults: national implications for rhythm management and stroke prevention: the AnTicoagulation and Risk Factors in Atrial Fibrillation (ATRIA) Study | Q29614197 | ||
Rivaroxaban versus warfarin in nonvalvular atrial fibrillation | Q29614696 | ||
Apixaban versus warfarin in patients with atrial fibrillation | Q29617563 | ||
A systematic review of the associations between dose regimens and medication compliance | Q30719289 | ||
Pharmacology and management of the vitamin K antagonists: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). | Q34012421 | ||
Apixaban in patients with atrial fibrillation | Q34163710 | ||
P433 | issue | 5 | |
P921 | main subject | atrial fibrillation | Q815819 |
P304 | page(s) | 287-294 | |
P577 | publication date | 2012-10-01 | |
P1433 | published in | American journal of cardiovascular drugs | Q2555367 |
P1476 | title | New anticoagulants for stroke prophylaxis in atrial fibrillation: assessing the impact on medication adherence | |
P478 | volume | 12 |
Q34834319 | Dabigatran versus warfarin under standard or pharmacogenetic-guided management for the prevention of stroke and systemic thromboembolism in patients with atrial fibrillation: a cost/utility analysis using an analytic decision model |
Q42697095 | Rates and predictors of 5-year survival in a national cohort of asymptomatic elderly patients undergoing carotid revascularization |
Q38107177 | Rivaroxaban: a review of its use in the prevention of stroke and systemic embolism in patients with atrial fibrillation |
Q37004184 | Who Were the Early Adopters of Dabigatran?: An Application of Group-based Trajectory Models |
Search more.